Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

CGEMCGEM
Showing 8 of 22 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in CULLINAN THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC holds 1.5M shares of CGEM (CULLINAN THERAPEUTICS INC), worth $28.2M as of 2026-Q2. The position was increased (+13.1% shares). CGEM represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$28.2M

Current Shares

1.5M

Total Value Change

+$7.9M

Total Shares Change

+338,888

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+13.1%
$28.2M0.0%$18.21
32
2026-Q1
Increased
1.4M
+5.1%
$19.4M0.0%$15.73
30
2025-Q4
Increased
1.3M
+0.5%
$13.5M0.0%$9.92
28
2025-Q3
Increased
1.3M
+1.2%
$7.7M0.0%$5.97
28
2025-Q2
Increased
1.3M
+3.0%
$9.6M0.0%$7.76
28
2025-Q1
Increased
1.2M
+2.2%
$9.4M0.0%$8.02
28
2024-Q4
Increased
1.2M
+0.5%
$14.8M0.0%$12.20
28
2024-Q3
Increased
1.2M
+23.8%
$20.2M0.0%$17.19
35

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used